We can’t show the full text here under this license.
Lipid nanoparticles with targeting molecules deliver mRNA specifically to CD4+ T cells
Updated
Abstract
Essence
-functionalized may enable more selective mRNA delivery to CD4+ T cells.
Evidence
This formulation and platform experiment tested SM102 or MC3 lipid nanoparticles conjugated to validated and AI-designed CD4-binding aptamers for binding, transfection, biodistribution, and safety in recombinant, cell, and in vivo systems.
Caveat
The abstract reports platform performance rather than therapeutic efficacy, and the text is partly garbled, limiting confidence in some experimental details.
Simplified
Key numbers
70-fold
Increase in Spleen Signal
Spleen signal enhancement compared to non-targeted controls.
100:1
Transfection Efficiency in CD4⁺ T Cells
Apt62 conjugation at a ratio of 100 per LNP.